E-B-FAHF-2, Multi OIT and Xolair for Food Allergy

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

August 20, 2016

Primary Completion Date

July 2, 2020

Study Completion Date

February 22, 2021

Conditions
Food Allergy
Interventions
DRUG

Drug: Chinese Herbal Medication

Capsules, 26 month course, starting 2 months pre-OIT.

DRUG

Drug: Placebo

Placebo capsules that look identical to E-B-FAHF-2 containing corn starch, 26 month course, starting 2 months pre-OIT

DRUG

Drug: Omalizumab

4 months course, starting 2 months pre-OIT through the 2 month build-up phase

Sponsors
All Listed Sponsors
collaborator

Icahn School of Medicine at Mount Sinai

OTHER

lead

New York Medical College

OTHER

NCT06103656 - E-B-FAHF-2, Multi OIT and Xolair for Food Allergy | Biotech Hunter | Biotech Hunter